ABC | Volume 111, Nº3, Setembro 2018

Artigo Original Nemes et al Função do AD na AC por 3DSTE Arq Bras Cardiol. 2018; 111(3):384-391 1. Dubrey SW, Hawkins PN, Falk RH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart. 2011;97(1):75-84. 2. BanypersadSM,MoonJC,WhelanC,HawkinsPN,WechalekarAD.Updates in cardiac amyloidosis: a review. J AmHeart Assoc. 2012;1(2):e000364. 3. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, et al. A primer of amyloid nomenclature. Amyloid. 2007;14(3):179-83. 4. FalkRH.Diagnosisandmanagementofthecardiacamyloidoses.Circulation. 2005;112(13):2047-60. 5. Westermark P, BensonMD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, et al.Amyloidfibrilproteinnomenclature-2002.Amyloid. 2002; 9(3):197-200. 6. Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, et al. Systemic cardiac amyloidoses disease profiles and clinical courses of the 3main types. Circulation. 2009;120(13):1203-1212. 7. Chamarthi B, Dubrey SW, Cha K, SkinnerM, Falk RH. Features and prognosis of exertional syncope in light-chain associated AL cardiac amyloidosis. Am J Cardiol 1997;80(9):1242-5. 8. Gutierrez PS, Fernandes F, Mady C, Higuchi Mde L. Clinical, electrocardiographic and echocardiographic findings in significant cardiac amyloidosis detected only at necropsy: comparison with cases diagnosed in life. Arq Bras Cardiol. 2008;90(3):191-6. 9. Brodarick S, Paine R, Higa E, Carmichael KA. Pericardial tamponade, a new complication of amyloid heart disease. Am J Med. 1982;73(1):133-5. 10. Navarro JF, Rivera M, Ortuno J. Cardiac tamponade as presentation of systemic amyloidosis. Int J Cardiol. 1992;36(1):107-8. 11. Rai AB, Lima E, Munir F, Faisal Khan A, Waqas A, Bughio S, et al. Speckle tracking echocardiography of the right atrium: the neglected chamber. Clin Cardiol. 2015;38(11):692-7. 12. PelusoD, Badano LP, MuraruD, Dal Bianco L, Cucchini U, Kocabay G, et al. Right atrial size and function assessed with three-dimensional and speckle- tracking echocardiography in 200 healthy volunteers.Eur Heart J Cardiovasc Imaging. 2013;14(11):1106-14. 13. Gertz MA, Comenzo R, Falk RH, Fermand JP, Hazenberg BP, Hawkins PN, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposiumon Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005;79(4):319-28. 14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. American Society of Echocardiography’’s nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79-108. 15. Rudski LG, LaiWW, Afilalo J,Hua L, HandschumacherMD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the rigth heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713. 16. Nemes A, Kalapos A, Domsik P, Forster T. [Three-dimensional speckle- tracking echocardiography -- a further step in non-invasive three- dimensional cardiac imaging]. Orv Hetil. 2012;153(40):1570-7. 17. Nemes A, Havasi K, Domsik P, Kalapos A, Forster T. Evaluation of right atrial dysfunction in patients with corrected tetralogy of Fallot using 3D speckle- tracking echocardiography. Insights from the CSONGRAD Registry and MAGYAR-Path Study. Herz. 2015;40(7):980-8. 18. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32(1):45-59. 19. Urbano-Moral JA, Gangadharamurthy D, Comenzo RL, Pandian NG, Patel AR. Three-dimensional Speckle Tracking Echocardiography in light chain cardiac amyloidosis: examination of left and right ventricular myocardial mechanics parameters. Rev Esp Cardiol (Engl Ed). 2015;68(8):657-64. 20. MerliniG,StoneMJ.DangeroussmallB-cellclones.Blood.2006;108(8):2520-30. 21. Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, et al. SerumcardiactroponinsandN-terminalpro–brainnatriureticpeptide:astaging system for primary systemic amyloidosis. J ClinOncol. 2004;22(18):3751-7. 22. Patel AR, Dubrey SW, Mendes LA, Skinner M, Cupples A, Falk RH, et al. Right ventricular dilation in primary amyloidosis: an independent predictor of survival. Am J Cardiol. 1997;80(4):486-92. 23. Porciani MC, Lilli A, Perfetto F, Cappelli F, Massimiliano Rao C, Del Pace S, et al. Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid. 2009;16(2):63-70. 24. Tsang W, Lang RM. Echocardiographic evaluation of cardiac amyloid. Curr Cardiol Rep. 2010;12(3):272-6. 25. Bellavia D, Pellikka PA, Abraham TP, Al-Zahrani GB, Dispenzieri A, Oh JK, et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol. 2008;101(7):1039-45. 26. Bellavia D, Pellikka PA, Dispenzieri A, Scott CG, Al-Zahrani GB, Grogan M, et al.Comparisonofrightventricular longitudinalstrainimaging,tricuspidannular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study. Eur Heart J Cardiovasc Imaging. 2012;13(8):680-9. 27. SzczygiełJA,WieczorekPZ,Drozd-SokołowskaJ,MichałekP,MazurkiewiczŁ, Legatowicz-KoprowskaM,etal.Impairedrightventricularfunctionasapredictor of early mortality in patients with light‑chain cardiac amyloidosis assessed in a cardiology department. Pol Arch InternMed. 2017;127(12):854-64. 28. FöldeákD,KormányosÁ,DomsikP,KalaposA,PirosGÁ,AmbrusN,etal.Leftatrial dysfunctioninlight-chaincardiacamyloidosisandhypertrophiccardiomyopathy -Acomparativethree-dimensionalspeckle-trackingechocardiographicanalysis fromtheMAGYAR-PathStudy.RevPortCardiol.2017;36(12):905-13. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 391